These results suggested that ILA protects against colitis and intestinal inflammation by modulating the intestinal microbiota, consistent with an earlier report that L. reuteri-mediated differentiation of the intestinal intraepithelial lymphocytes is ILA-dependent and relies on the presence of the intestinal microbiota [11]. Here, TNFRSF9 is linked to colitis.